Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| The Scientific and Technological Research Council of Turkey | OTHER |
Not provided
Not provided
Not provided
Not provided
The aim of this study is to evaluate the effect of telenursing interventions based on the empowerment model in empowering patients with COPD.
Patient empowerment is gaining importance and popularity day by day as it can be sustained through telehealth applications. The importance of using communication technologies in providing health care services has become more evident during the COVID-19 pandemic. When integrated into healthcare, technology-centric services provide continuous and easily accessible health data for patients and help facilitate self-monitoring. With tele-nursing, COPD patients can be strengthened in health literacy by teaching them how to access accurate and reliable resources. Through tele-nursing, online support groups and forums can be created among COPD patients so that patients can share their experiences with each other. In this way, social support is provided to patients who have to remain in social isolation due to their illness.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Telenursing Interventions Group | Experimental | Participants in this group will receive five hours of face-to-face empowerment training. After the training, the experimental group will be monitored remotely by the researcher nurse via tele-nursing interventions for 12 weeks. Participants will be given a pulse oximeter, symptom diary, action plan, oxygen saturation-pulse monitoring chart. Participants will be asked to measure their oxygen saturation and pulse once a day for 12 weeks and record it on the chart. Participants will also be asked to record their complaints in their symptom diary. Participants will be called by the researcher every two weeks (on Thursdays) and informative and reminding text messages prepared specifically for the disease will be sent to the participants three times a week for 12 weeks. Participants will be able to reach the researchers by phone whenever they need. |
|
| No Intervention Group | No Intervention | Participants in this group will be given a pulse oximeter, symptom diary, action plan, oxygen saturation-pulse monitoring chart. No intervention will be taken. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Telenursing Interventions | Other | Patient follow-up with phone calls and text messages |
|
| Measure | Description | Time Frame |
|---|---|---|
| COPD Empowerment Scale | A 31-item scale that evaluates the impact of interventions on individuals with COPD. | Pre-test, Post-test (3rd month), Follow-up Test (6th month) |
| Measure | Description | Time Frame |
|---|---|---|
| Lung Function Test | A spirometri test that evaluates lung capacity. FEV1 values will increase after the intervention. | Pre-test, Post-test (3rd month), Follow-up Test (6th month) |
| COPD Assesment Test |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Zahide Aksoy, MSc | Marmara University | Principal Investigator |
| Saime Erol, Ph.D | Marmara University | Study Director |
| Özlem Oruç, M.D | Sureyyapasa Chest Diseases and Thoracic Surgery Training and Research Hospital | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Sureyyapasa Chest Diseases and Thoracic Surgery Training and Research Hospital | Istanbul | Maltepe | 34844 | Turkey (Türkiye) |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 41420230 | Derived | Aksoy Z, Erol S, Oruc O. Effects of empowerment model-based telenursing interventions on empowerment in individuals with COPD. BMC Nurs. 2025 Dec 19;25(1):52. doi: 10.1186/s12912-025-04225-z. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D029424 | Pulmonary Disease, Chronic Obstructive |
| D000079102 | Empowerment |
| D010358 | Patient Participation |
| ID | Term |
|---|---|
| D008173 | Lung Diseases, Obstructive |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |
| D002908 | Chronic Disease |
Not provided
Not provided
Two groups with experimental and control groups
Not provided
Not provided
In order to prevent selection bias in the study, the assignment to the experimental and control groups will be made on a computer by a person who is unfamiliar with the research process. Individuals included in the study will not be told whether they are in the experimental or control group. The analysis of the data will be done by a statistics expert who is outside the research process.
It is an eight-item test that measures the effects of COPD and deterioration in health status. CAT assessment test score; 0-10 is low 11-20 is considered medium effective, 21-30 is considered highly effective, and 31-40 is considered very high effective.
| Pre-test, Post-test (3rd month), Follow-up Test (6th month) |
| Number of hospital admissions due to COPD exacerbation | The number of hospital admissions due to COPD exacerbation in the experimental group will decrease. | Pre-test, Post-test (3rd month), Follow-up Test (6th month) |
| Number of hospitalizations due to COPD exacerbation | The number of hospitalizations due to COPD exacerbation in the experimental group will decrease. | Pre-test, Post-test (3rd month), Follow-up Test (6th month) |
| Modified Barthel Index | A scale that evaluates physical competence and independence in daily living activities. It evaluates 0-15 points with 10 items. On this scale, where the possible score varies between 0 and 100, the higher the score, the more independent the patient is from other people. | Pre-test, Post-test (3rd month), Follow-up Test (6th month) |
| Modified Medical Research Council | A brief 5-item scale describing dyspnea. Scores between 0 and 1 are considered mild, and scores of 2 and above are considered moderate to severe dyspnea. | Pre-test, Post-test (3rd month), Follow-up Test (6th month) |
| Inhaler Device Use Skill Scale | An observational test that measures inhaler device usage skill, with 10 usage steps explained. 1 point for correct use of each item; Incomplete or incorrect use is given 0 points. | Pre-test, Post-test (3rd month), Follow-up Test (6th month) |
| D020969 |
| Disease Attributes |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D012919 | Social Behavior |
| D001519 | Behavior |
| D010342 | Patient Acceptance of Health Care |
| D000074822 | Treatment Adherence and Compliance |
| D015438 | Health Behavior |